Local Institution - 0005 — New York, New York

Local Institution - 0005 is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Local Institution - 0005 has participated in 6 clinical trials.

Therapeutic areas: Hodgkin Disease, Advanced Pancreatic Cancer, Stage IV or Recurrent Non-Small Cell Lung Cancer.

Sponsors: Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0005?

Local Institution - 0005 has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0005 conducted?

Local Institution - 0005 has 6 clinical trials on record. Their work covers Hodgkin Disease, Advanced Pancreatic Cancer, Stage IV or Recurrent Non-Small Cell Lung Cancer.

Is Local Institution - 0005 accredited by Crixeo Health?

Local Institution - 0005 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0005?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.